| Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma (NCT01307605) | Swiss Cancer Institute | 2011-02-09 |
| Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma (NCT01307592) | Auxilio Mutuo Cancer Center | 2011-02-01 |
| Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis (NCT01301417) | novoGI | 2011-02-01 |
| A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias (NCT01287104) | National Cancer Institute (NCI) | 2011-01-29 |
| Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease (NCT00448201) | UNC Lineberger Comprehensive Cancer Center | 2011-01-07 |
| Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation (NCT01891578) | Armando Santoro, MD | 2011-01-01 |
| Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma (NCT01276717) | University of Rochester | 2011-01-01 |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab (NCT01150643) | Eastern Cooperative Oncology Group | 2010-12-06 |
| A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002) (NCT01244009) | Tesaro, Inc. | 2010-12-01 |
| A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy (NCT00558675) | Mirror Biologics, Inc. | 2010-12-01 |
| Ultrasonographic Differentiation Between Kikuchi's Disease and Lymphoma in Patients With Cervical Lymphadenopathy (NCT01310933) | Far Eastern Memorial Hospital | 2010-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant (NCT01118013) | Alliance for Clinical Trials in Oncology | 2010-12-01 |
| Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma (NCT01231269) | Universitaire Ziekenhuizen KU Leuven | 2010-11-01 |
| An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas (NCT01240577) | National Cancer Institute (NCI) | 2010-10-26 |
| RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01236586) | National Cancer Institute (NCI) | 2010-10-08 |
| Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT01169532) | Fox Chase Cancer Center | 2010-10-01 |
| Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP (NCT01210287) | Fudan University | 2010-10-01 |
| Italian Platelet Technology Assessment Study (NCT01642563) | Centro Nazionale Sangue | 2010-10-01 |
| Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL) (NCT01213095) | Dong-A University Hospital | 2010-09-01 |
| PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma (NCT02601547) | University Hospital, Toulouse | 2010-09-01 |
| Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL) (NCT01120834) | Weill Medical College of Cornell University | 2010-09-01 |
| Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia (NCT02520895) | Hospices Civils de Lyon | 2010-09-01 |
| Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma (NCT01118026) | Alliance for Clinical Trials in Oncology | 2010-09-01 |
| To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer (NCT01222780) | Acrotech Biopharma Inc. | 2010-09-01 |
| Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers (NCT01135329) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2010-08-01 |
| Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation (NCT01116232) | Barbara Ann Karmanos Cancer Institute | 2010-08-01 |
| Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients (NCT01169584) | Jennerex Biotherapeutics | 2010-08-01 |
| Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma (NCT01180569) | Memorial Sloan Kettering Cancer Center | 2010-08-01 |
| Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer (NCT01164709) | Swiss Cancer Institute | 2010-07-01 |
| A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma (NCT01185548) | Eli Lilly and Company | 2010-07-01 |
| S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma (NCT01131221) | SWOG Cancer Research Network | 2010-06-01 |
| A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer (NCT01149668) | Pharmacyclics LLC. | 2010-06-01 |
| Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma (NCT01139359) | Alaunos Therapeutics | 2010-06-01 |
| A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas (NCT01132911) | National Cancer Institute (NCI) | 2010-05-10 |
| Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC) (NCT01186224) | University of Liverpool | 2010-05-01 |
| SCRI Tissue Testing Registry (NCT00965861) | SCRI Development Innovations, LLC | 2010-05-01 |
| Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT00963274) | Virginia Commonwealth University | 2010-04-26 |
| Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab (NCT01131208) | ECOG-ACRIN Cancer Research Group | 2010-04-21 |
| International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients (NCT01111201) | Memorial Sloan Kettering Cancer Center | 2010-04-01 |
| Autologous Transplant in HIV Patients (BMT CTN 0803) (NCT01141712) | Medical College of Wisconsin | 2010-04-01 |
| Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas (NCT01078649) | Debiopharm International SA | 2010-03-29 |
| TTP607 in Refractory Solid Malignancies (NCT00939172) | M.D. Anderson Cancer Center | 2010-03-01 |
| Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection (NCT01095757) | Emory University | 2010-03-01 |
| Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer (NCT00963872) | Masonic Cancer Center, University of Minnesota | 2010-03-01 |
| Circulating microRNAs as Disease Markers in Pediatric Cancers (NCT01541800) | Ann & Robert H Lurie Children's Hospital of Chicago | 2010-03-01 |
| Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome (NCT00946283) | Rutgers, The State University of New Jersey | 2010-03-01 |
| Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma (NCT01029730) | SCRI Development Innovations, LLC | 2010-03-01 |
| DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701 (NCT01057459) | Alliance for Clinical Trials in Oncology | 2010-02-01 |
| Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides (NCT01073267) | M.D. Anderson Cancer Center | 2010-02-01 |
| Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01027000) | Alliance for Clinical Trials in Oncology | 2010-02-01 |
| Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant (NCT01077440) | Vanderbilt University | 2010-02-01 |
| A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas (NCT01051635) | National Cancer Institute (NCI) | 2010-01-25 |
| A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). (NCT01021358) | Abbott | 2010-01-01 |
| Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma (NCT00904722) | M.D. Anderson Cancer Center | 2010-01-01 |
| Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization (NCT01037517) | CancerCare Manitoba | 2010-01-01 |
| PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients (NCT00948090) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-01-01 |
| Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine (NCT01022021) | University of Kansas Medical Center | 2010-01-01 |
| Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma (NCT00967044) | M.D. Anderson Cancer Center | 2009-11-01 |
| Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NCT01088750) | Christine Mauz-Körholz | 2009-11-01 |
| Safety Study of ON 013105 in Lymphoma and Acute Lymphoid Leukemia (NCT01049113) | Traws Pharma, Inc. | 2009-11-01 |
| Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy (NCT01016548) | University Health Network, Toronto | 2009-11-01 |
| AIMN Multicenter Study: Staging of Lymphomas Using PET/CT (NCT06179693) | IRCCS San Raffaele | 2009-10-07 |
| Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation (NCT00996359) | University of Medicine and Dentistry of New Jersey | 2009-10-01 |
| Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma (NCT00935844) | Millennium Pharmaceuticals, Inc. | 2009-10-01 |
| Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation (NCT00990249) | M.D. Anderson Cancer Center | 2009-10-01 |
| Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients (NCT01394640) | Paolo Corradini | 2009-10-01 |
| Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL (NCT00772668) | University of Miami | 2009-09-25 |
| 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer (NCT00935090) | Barbara Ann Karmanos Cancer Institute | 2009-09-01 |
| Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (NCT00989586) | Beth Christian | 2009-09-01 |
| Registry of Older Patients With Cancer (NCT01137825) | UNC Lineberger Comprehensive Cancer Center | 2009-09-01 |
| Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer (NCT00949117) | University of South Florida | 2009-09-01 |
| Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma (NCT00987493) | Swiss Cancer Institute | 2009-09-01 |
| Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma (NCT00983944) | Ohio State University Comprehensive Cancer Center | 2009-09-01 |
| Infusion of Expanded Cord Blood T Cells (NCT00972101) | M.D. Anderson Cancer Center | 2009-09-01 |
| Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma (NCT00981097) | AIDS Malignancy Consortium | 2009-08-01 |
| Study of Bortezomib in Combination With Cyclophosphamide and Rituximab (NCT00958256) | M.D. Anderson Cancer Center | 2009-08-01 |
| Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma (NCT00978523) | Arno Therapeutics | 2009-08-01 |
| Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia (NCT01016990) | Auxilio Mutuo Cancer Center | 2009-08-01 |
| Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor (NCT00967343) | Kiadis Pharma | 2009-08-01 |
| A Study of IXAZOMIB in Adult Patients With Lymphoma (NCT00893464) | Millennium Pharmaceuticals, Inc. | 2009-08-01 |
| Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma (NCT00868608) | Pfizer | 2009-07-30 |
| Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma (NCT00980395) | University of Arizona | 2009-07-07 |
| Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma (NCT00962507) | City of Hope Medical Center | 2009-07-01 |
| S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma (NCT00822120) | SWOG Cancer Research Network | 2009-07-01 |
| Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab (NCT00946023) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-07-01 |
| Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT00908180) | Cancer Research UK | 2009-07-01 |
| Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer (NCT01137643) | UNC Lineberger Comprehensive Cancer Center | 2009-07-01 |
| Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL (NCT00881920) | Baylor College of Medicine | 2009-07-01 |
| Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma (NCT00907036) | Cancer Research UK | 2009-07-01 |
| A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY) (NCT00932854) | University College London Hospitals | 2009-07-01 |
| Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor (NCT01362985) | Genzyme, a Sanofi Company | 2009-07-01 |
| Breathing Adapted Radiotherapy for Mediastinal Lymphoma (NCT00928096) | Peter Meidahl Petersen | 2009-06-01 |
| Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY (NCT00809276) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-05-01 |
| Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma (NCT00901069) | Shams Shakil | 2009-05-01 |
| Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT) (NCT01004718) | Abramson Cancer Center at Penn Medicine | 2009-05-01 |
| Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial (NCT00924131) | National Cancer Institute (NCI) | 2009-04-17 |
| Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103) (NCT00875056) | Merck Sharp & Dohme LLC | 2009-04-15 |
| S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma (NCT00770224) | SWOG Cancer Research Network | 2009-04-01 |
| Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP (NCT01122472) | The Lymphoma Academic Research Organisation | 2009-04-01 |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy (NCT00891137) | Cellerant Therapeutics | 2009-04-01 |